| Literature DB >> 34686880 |
Nils Karl Josef Ecker1, Gabriela Möslein2,3, Karl-Wilhelm Ecker4,5.
Abstract
BACKGROUND: Continent ileostomy (CI) aims to provide control of gas and faecal evacuation; however, it is rarely performed. This paper reports on outcomes of CI in a large single-surgeon series.Entities:
Mesh:
Year: 2021 PMID: 34686880 PMCID: PMC8536872 DOI: 10.1093/bjsopen/zrab095
Source DB: PubMed Journal: BJS Open ISSN: 2474-9842
Patient characteristics
| No. of patients | |
|---|---|
|
| |
| Ulcerative colitis | 31 (50.0) |
| Crohn’s colitis | 17 (27.4) |
| Familial adenomatous polyposis | 11 (17.7) |
| Other non-inflammatory | 3 (4.8) |
|
| |
| Elective | 55 (88.7) |
| Urgent | 6 (9.7) |
| Emergency | 1 (1.6) |
|
| |
| Refractory to medical treatment | 47 (75.8) |
| Intraepithelial neoplasia | 11 (17.7) |
| Carcinoma | 6 (9.7) |
| Toxic megacolon | 4 (6.5) |
| Massive bleeding | 2 (3.2) |
| Perforation | 2 (3.2) |
|
| |
| Contraindication to IPAA | 19 (30.6) |
| Refused IPAA | 16 (25.8) |
| Contraindication to IS | 17 (27.4) |
| Refused IS | 10 (16.2) |
|
| |
| Primary CI construction (1 stage) | 25 (40.3) |
| Secondary CI construction (2 stage) | 37 (59.7) |
|
| |
| Onset of disease ( | 26.4(12.9) |
| Proctocolectomy and CI construction ( | 40.7(13.6) |
| Primary colectomy ( | 33.3(9.5) |
| Secondary CI construction ( | 42.2(10.7) |
*With percentages in parentheses unless indicated otherwise
†values are mean(s.d.).
‡Seventy-two different indications in 62 patients.
§Forty-two contraindications in 19 patients: carcinoma (5), anal destruction (13), incontinence (16), and technical problems in performing ileal pouch–anal anastomosis (IPAA) (8).
¶Eighteen contraindications in 17 patients: skin complications (5), problems with stoma appliances (8), and stoma complications (5). CI, continent ileostomy; IS, conventional ileostomy.
Early complications (group I)
| No. of patients | Treatment | Outcome | |
|---|---|---|---|
|
| 10 | Urgent revision 10 | Successful 7 |
| Peritonitis/abscess | 2 | Relaparotomy 2 | Death 1 |
| Pouch ischaemia | 2 | Redo surgery 2 | Failure 1 |
| NV necrosis | 1 | NV reconstruction 1 | |
| NV fistula | 1 | Fistula closure 1 | Failure 1 |
| Ileus | 3 | Adhesiolysis 3 | |
| Soft tissue abscess | 1 | Drainage 1 | |
|
| 19 | Elective revision 19 | Successful 19 |
| Stoma complications | 7 | ||
| Stenosis | 3 | Local repair 3 | |
| Retraction | 1 | Local repair 1 | |
| Parastomal hernia | 3 | Local repair 3 | |
| NV complications | 14 | ||
| Total necrosis | 1 | NV reconstruction 1 | |
| Partial necrosis, nipple shortening | 6 | NV reconstruction 6 | |
| Fistula | 7 | Fistula closure 5 | |
| NV reconstruction 2 |
*Including one non-lethal failure in group Ia.
†Five of seven patients also had complications of the nipple valve (NV), resulting in a total of 19 patients in group Ib.
Late complications (group II)
| Sequence | No. of patients | Overall no. of procedures | Site of revision | |||
|---|---|---|---|---|---|---|
| Stoma | Nipple valve | Pouch | Afferent loop | |||
| First revision | 23 (38.3) | 38 | 10 | 18 | 6 | 4 |
| Second revision | 11 (18.3) | 23 | 4 | 14 | 3 | 2 |
| Third revision | 4 (6.7) | 12 | 2 | 7 | 1 | 2 |
| Fourth revision | 2 (3.3) | 4 | 0 | 4 | 0 | 0 |
| Fifth revision | 2 (3.3) | 2 | 0 | 2 | 0 | 0 |
| All procedures | 42 | 79 | 16 | 45 | 10 | 8 |
Values in parentheses are percentages based on cohort of 60 patients with perfect function after the first postoperative year.
*Multiple complications were possible in a patient at the time of revision.
Complications leading to first to fifth revision surgery in the long term, and associated repair procedures
| Site and type of complication | No. of procedures | Surgical procedures |
|---|---|---|
|
| 16 | |
| Retraction, stenosis | 13 | Local plastic correction 13 |
| Abscess, fistula | 2 | Drainage + fistula closure 2 |
| Parastomal hernia | 1 | Hernia repair 1 |
|
| 46 | |
| Sliding/prolapse | 41 | Restabilization of existing valve 11 |
| Reconstruction of valve from afferent loop 19 | ||
| Reconstruction of valve from oral loop 11 | ||
| Fistula | 5 | Fistula closure 2 |
| Fistula closure protected by loop ileostomy 2 | ||
| Reconstruction of valve from afferent loop 1 | ||
|
| 10 | |
| Pouchitis | 2 | Pouch resection + permanent ileostomy 2 |
| Displacement | 2 | Replacement and fixation 2 |
| Fistula | 6 | Fistula closure 4 |
| Pouch resection + permanent ileostomy 2 | ||
|
| 8 | |
| Stenosis | 2 | Ileal resection + anastomosis 1 |
| Bypass between prestenotic ileum and pouch 1 | ||
| Fistula | 6 | Ileal resection + anastomosis 4 |
| Excision and stricture plasty 2 | ||
|
| 80 |
*Pouch preservation was not possible in four patients; the other 76 revisional procedures were successful.
Subgroup analysis of complication rates: primary versus secondary construction
| Primary construction | Secondary construction |
| |
|---|---|---|---|
| Group Ia | 8 of 25 | 2 of 37 | 0.005 |
| Group Ib | 5 of 23 | 14 of 37 | 0.190 |
| Group II | 9 of 23 | 14 of 37 | 0.222 |
*Two patients were lost from from group 1a (sepsis-related mortality and pouch loss). †χ2 test.
Subgroup analysis of complication rates by underlying disease
| Ulcerative colitis | Crohn’s colitis | Non-IBD |
| |
|---|---|---|---|---|
| Group Ia | 5 of 31 | 3 of 17 | 2 of 14 | 0.831 |
| Group Ib | 10 of 31 | 6 of 15 | 3 of 14 | 0.108 |
| Group II | 11 of 31 | 8 of 15 | 4 of 14 | 0.111 |
IBD, inflammatory bowel disease.
*χ2 test.